Kenneth Eakin
Family Medicine · Glen Carbon, ILNPI 1174529556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 32.8% of the total. Reporting peaked in 2019 at $1,183 and has fallen 90.5% since, to $112 in 2021.
Across 134 payments — averaging $15.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$660
- Novo Nordisk$176
- Pfizer$147
- Lilly USA, LLC$128
- Amarin Pharma, Inc.$120
- Amgen$101
- plus $678 from 20 others
What the payments were for
- Food & beverage$2,010100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $660 |
| Novo Nordisk | 13 | $176 |
| Pfizer | 13 | $147 |
| Lilly USA, LLC | 9 | $128 |
| Amarin Pharma, Inc. | 7 | $120 |
| Amgen | 6 | $101 |
| Merck | 7 | $91 |
| Kowa Pharmaceuticals America, Inc. | 6 | $88 |
| Astellas Pharma US Inc | 5 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $44 |
| Boehringer Ingelheim | 3 | $43 |
| Abbott | 2 | $35 |
| GSK | 3 | $34 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Novartis | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Shire North American Group Inc | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $27 |
| Bristol Myers Squibb | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Antares Pharma, Inc. | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
How this compares
$2,010 in reported general payments places this provider in the 80th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrochlorothiazide | 60 | $282 |
| Metoprolol Tartrate | 60 | $255 |
| Simvastatin | 51 | $228 |
| Lisinopril | 51 | $204 |
| Timolol Maleate | 13 | $154 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Glen Carbon
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.